Sector
PharmaceuticalsOpen
₹1.97Prev. Close
₹2.07Turnover(Lac.)
₹2.03Day's High
₹2.07Day's Low
₹1.9752 Week's High
₹052 Week's Low
₹0Book Value
₹-5.39Face Value
₹10Mkt Cap (₹ Cr.)
5.15P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Equity Capital | 24.88 | 24.88 | 24.88 | 29.26 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.37 | 3.81 | 4.49 | 4.4 |
Net Worth | 28.25 | 28.69 | 29.37 | 33.66 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Revenue | 14.4 | 28.76 | 13.36 | 2.98 |
yoy growth (%) | -49.93 | 115.31 | 347.99 | -87.06 |
Raw materials | -14.36 | -28.38 | -12.72 | -2.8 |
As % of sales | 99.75 | 98.65 | 95.23 | 94.04 |
Employee costs | -0.09 | -0.09 | -0.08 | -0.11 |
Y/e 31 Mar( In .Cr) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Profit before tax | -0.93 | -0.73 | 0.15 | -0.4 |
Depreciation | -0.91 | -0.99 | -0.11 | -0.07 |
Tax paid | 0.49 | 0.05 | -0.05 | 0 |
Working capital | -0.21 | -0.38 | 0.54 | -0.12 |
Other operating items |
Y/e 31 Mar | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -49.93 | 115.31 | 347.99 | -87.06 |
Op profit growth | -154.58 | -16.37 | -189.58 | 46.14 |
EBIT growth | 27.78 | -531.52 | -143.71 | -203.62 |
Net profit growth | -35 | -812.06 | -123.83 | -243.51 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,704.65 | 133.02 | 4,19,043.85 | 1,181.05 | 0.77 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,836.45 | 76.96 | 1,59,537.33 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,459.05 | 25.54 | 1,18,888.86 | 1,438.15 | 0.88 | 4,134.87 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,011.5 | 57.05 | 1,04,058.84 | 485 | 0.91 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,396.85 | 53.3 | 1,03,057.15 | 416.38 | 0 | 2,396.57 | 334.18 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director & CEO
Y Manivardhan Reddy
Whole Time Director & CFO
Y Sonia Reddy
Director
P Naveen Chander Reddy
Director
P Suresh Reddy
Additional Director
Santosh Jagannath Sawant
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Saamya Biotech India Ltd
Summary
Saamya Bio-tech (India) Ltd was incorporated as a Public Limited Company on August 13, 2002. With the primary objective to carry on the business of manufacture, buy, import, export and generally deal in all types of chemicals, pharmaceuticals, drugs and intermediates. Presently, the Company is not undertaking any activity.The Company has proposes to set up manufacturing facility in Shapoorji Pallonji Biotech Park Pvt Ltd, at Kolthur village, Shameerpet Mandal, Rangareddy District, Andhra Pradesh to manufacture low volume high value active Bio-Pharmaceutical ingredients viz., Daunomycin (anti-cancer), Hyaluronic Acid - Pharma Grade (Ophthalmic medicine) and Cosmetic Grade.The Company has entered into technology transfer agreement with Biofin laboratories S.R.L Italy for Technology Know-How to manufacture Bio-Pharmaceutical ingredients.The Company has entered into sales and purchase agreement with M/s Finchimica, Italy on September 18, 2004, in terms of which M/s Finchimica, Italy would buy all the products manufactured by the company to the extent of 100%.The detailed engineering and for civil design (in accordance with the regulations of USFDA. and European drug standards) of the plant is being done by M/s. Shapoorji Pallonji and Company Ltd., Mumbai (SPCL). The Company has already entered into an agreement with M/s. Shapoorji Pallonji and Company Ltd.
Read More
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.